Mark Guzman is an Executive Director and Product Strategy Leader at Gilead Sciences, where they focus on strategic product development. Their extensive experience includes roles at Genentech as a Technical Product Leader and at Onyx Pharmaceuticals as a Global CMC Project Leader. Mark has also served as Vice President of CMC Technologies at Dynavax Technologies and held scientific positions at Pfizer and DuPont Pharmaceuticals. They earned a Ph.D. in Organic Chemistry from the University of Pennsylvania and a B.S. in Chemistry from the University of Illinois Urbana-Champaign.
This person is not in the org chart
This person is not in any teams
This person is not in any offices